ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in July 2020. Updated July 31.
A round-up of FDA’s actions in July 2020.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in July 2020. Updated July 31.
A round-up of FDA’s actions in July 2020.